AzTrials
AzTrials

Depressive SymptomsNCT04277793

Feasibility Evaluation of a Monitored Self-guided Cognitive Behavioural Therapy Digital Format

A study testing Monitored self-guided problem solving in people with Depressive Symptoms and Anxiety, run by Karolinska Institutet at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to evaluate the feasibility of a new monitored self-guided digital cognitive behavioural therapy format through one of the key components of an intervention for depression and anxiety (Problem Solving) and to answer the question: Do patients with significant levels of depression and/or… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Depressive Symptoms, Anxiety
What is being tested?
Monitored self-guided problem solving
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteSweden
Study dates
24 Apr 2020to 11 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Significant depression and/or anxiety symptoms measured with Patient Health Questionnaire (PHQ-9) and General Anxiety Disorder (GAD-7) (i.e. a PHQ-9 and/or GAD-7 score of ≥5).

Who cannot join

  • insufficient Swedish knowledge
  • minor (i.e. age <18 years)
  • high suicide risk (i.e. a score ≥4 on the ninth item on the Montgomery Åsberg Depression Scale, MADRS-S)
  • lack of access to a device with Internet connection (e.g. computer, mobile, tablet)
  • lack of access to a phone on which calls and SMS can be received
  • psychiatric or somatic problems that must be prioritized before or become an excessive obstacle to the intervention.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Centrum för Psykiatriforskning

    Stockholm

Other trials in Sweden

About this study

Official title: Feasibility Evaluation of a Monitored Self-guided Digital Cognitive Behavioural Therapy Format: an Uncontrolled Trial of a Problem Solving Intervention for Depression and Anxiety

The purpose of the study is to evaluate the feasibility of a new monitored self-guided digital cognitive behavioural therapy format through one of the key components of an intervention for depression and anxiety (Problem Solving) and to answer the question: Do patients with significant levels of depression and/or anxiety symptoms consider the monitored self-guided digital format usable and credible? An uncontrolled trial will explore participant's usability and treatment credibility ratings.

Read the detailed description

Objective. The purpose of the study is to evaluate the feasibility of a new monitored self-guided digital cognitive behavioural therapy format through one of the key components of an intervention for depression and anxiety (Problem Solving) and to answer the question: Do patients with significant levels of depression and/or anxiety symptoms consider the monitored self-guided digital format usable and credible?

Background. Problem Solving is a behavioral modification intervention focusing on the training of adaptive problem-solving skills in order to cope more effectively with everyday stressful events. It is one of the most well-examined therapeutic interventions for depression, with reliable support regarding symptom improvement in depression traditionally delivered with therapist-guidance when administered via the Internet. Since a new monitored self-guided digital intervention for depression and anxiety has been developed, including the key component Problem Solving, it is of importance to assess both the usability and treatment-credibility of this format to evaluate if it is feasible.

Methodology. Based on similar feasibility studies including around ten participants, a number of 16-30 participants will be included in this study to compensate for potential drop-outs. Participants will be recruited via a psychiatric clinic belonging to Stockholm County Council in Stockholm, Sweden, and will be patients in queue for treatment for depression and/or anxiety in a psychiatric setting. Inclusion criteria will be significant depression and/or anxiety symptoms. The participants included in the study will access the key component Problem Solving during four weeks while being on waitlist for regular treatment. They will be introduced to the intervention as a self-explanatory tool with possible beneficial effects on depression symptoms. Self-assessments will be carried out during the intervention. The scores on these scales will be compared to available published data from these scales from evaluations of therapist-guided Internet-based interventions if available, and otherwise data from these scales from studies on other digital interventions for mental health. The participants will also answer questions concerning their experience of the format.

Being tested
Monitored self-guided problem solving
Keywords
CBT, Digital, Internet-based, Depression, Anxiety, Self-guided, Problem Solving, ICBT
Medical subject headings
Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Monitored self-guided problem solvingBehavioural

    Problem Solving is a behavioral modification intervention focusing on the training of adaptive problem-solving skills in order to cope more effectively with everyday stressful events.

Study groups in NCT04277793
Study groupRoleWhat they receive
Monitored self-guided problem solving interventionExperimentalMonitored self-guided problem solving intervention
Receives: Behavioral: Monitored self-guided problem solving

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. System Usability Scale

    Self-rated assessment of usability, higher score is better

    Measured: immediately after the intervention

  2. Treatment Credibility Scale

    Self-rated assessment of treatment credibility, higher score is better

    Measured: immediately after the intervention

Secondary outcomes (6)
  1. Negative Effects Questionnaire

    Self-rated assessment of negative treatment effects, lower score is better

    Measured: immediately after the intervention

  2. Negative Effects Questionnaire

    Self-rated assessment of negative treatment effects, lower score is better

    Measured: During the intervention: 2 weeks from baseline

  3. Patient Health Questionnaire - 9

    Self-rated depressive symptoms, lower score is better

    Measured: Change from baseline immediately after the intervention

  4. Generalized Anxiety Disorder - 7

    Self-rated anxiety symptoms, lower score is better

    Measured: Change from baseline immediately after the intervention

  5. System Usability Scale

    Self-rated assessment of usability, higher score is better

    Measured: During the intervention: 2 weeks from baseline

  6. Treatment Credibility Scale

    Self-rated assessment of treatment credibility, higher score is better

    Measured: During the intervention: 2 weeks from baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Feb 2020
  2. Study start24 Apr 2020
  3. Primary completion11 Dec 2020
  4. Study completion11 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04277793
Sponsor's protocol ID
SVPSY290/19
Status last verified
Dec 2020
First submitted
11 Feb 2020
Last updated
14 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Monitored self-guided problem solving in people with Depressive Symptoms and Anxiety, run by Karolinska Institutet at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

System Usability Scale (time frame: immediately after the intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Dec 2020; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in